Autolus Faces Life After Woodford With New Czech Backer
Executive Summary
PPF has bought a big stake in the UK-based T-cell specialist, one of many firms backed by investor Neil Woodford which have suffered stock slides in the past few months.
You may also be interested in...
Woodford Woes Drag On For Immunocore
Once seen as the champion of biotech start-ups, Woodford’s blind faith has shackled firms to unrealistic valuations.
'Serial Killer’ CAR-T Could Help Autolus Bounce Back
Data presentations at next week’s ASH meeting will be vital for Autolus to restore confidence in pipeline.
European Biotechs Enter the IPO Big League
2019 has seen European biotech companies making waves in the US IPO space. Genmab’s listing was a blockbuster, but many more companies have proven their ability to go public on the NASDAQ.